Sodium Oxybate Solution
Category: Psychiatry
FDA status: To Be Discontinued · Last FDA update: Dec 29, 2025 · First posted: Dec 29, 2025 · 1 manufacturers, 1 listed presentations
As of Dec 29, 2025, the FDA lists Sodium Oxybate Solution as being discontinued. Of 1 manufacturer presentations, 1 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Sodium Oxybate, Solution, .5 g/1 mL (NDC 69238-2391-1) NDC 69238-2391-1 |
Amneal Pharmaceuticals | Not specified | Discontinuation of the manufacture of the drug |
Related medications in shortage
Other Psychiatry medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Sodium Oxybate Solution (FDA data as of Dec 29, 2025). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Sodium Oxybate Solution. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/sodium-oxybate-solution.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).